Cornerstone Investment Partners, LLC Vanda Pharmaceuticals Inc. Transaction History

Cornerstone Investment Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$15.69 - $21.14 $179,744 - $242,179	-11,456 Closed	0 $0
Q3 2021 Oct 25, 2021	SELL	$15.35 - $21.27 $39,111 - $54,195	-2,548 Reduced 18.19%	11,456 $196,000
Q2 2021 Jul 29, 2021	BUY	$15.71 - $21.51 $471 - $645	30 Added 0.21%	14,004 $301,000
Q1 2021 Apr 26, 2021	BUY	$13.42 - $20.28 $416 - $628	31 Added 0.22%	13,974 $210,000
Q4 2020 Jan 28, 2021	BUY	$9.77 - $13.81 $136,223 - $192,552	13,943 New	13,943 $183,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $288M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Cornerstone Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cornerstone Investment Partners, LLC with notifications on news.